ARTICLES
FDA approves Kyprolis therapy for multiple myeloma
January 22, 2016
Stundick joins Spero Therapeutics
January 22, 2016
Eisai's Lenvatinib receives FDA Priority Review
January 22, 2016
Parexel to acquire Health Advances
January 20, 2016
Recipharm appoints new key account director for Europe
January 20, 2016
Acorda to acquire Biotie Therapies for $363M
January 20, 2016
UCL launches $55M technology investment fund
January 20, 2016
Upcoming Events
-
21Oct